The effect of preoperative β-blocker use and race on long-term survival after coronary artery bypass grafting.
To date, racial differences in the long-term survival of coronary artery bypass grafting (CABG) patients who receive preoperative β-blockers have not been specifically examined. The purpose of this study was to examine the effect of preoperative β-blockers on long-term survival among black CABG patients and to compare the magnitude of this effect with white patients. A retrospective cohort study. A tertiary referral heart hospital. 13,354 patients undergoing CABG between 1992 and 2011. Hazard ratios (HR) and 95% confidence intervals (CI) were computed using a Cox regression model. A total of 1,448 (62%) black and 6,094 (55%) white patients had a history of preoperative β-blocker use. Among black patients, those receiving β-blockers survived longer than those not receiving β-blockers (adjusted HR = 0.77, 95% CI = 0.67-0.88). The survival advantage was comparable to that observed among white patients (adjusted HR = 0.88, 95% CI = 0.82-0.93). Black CABG patients benefited from preoperative β-blockers and the magnitude of the effect was comparable to that among white patients.